Global Cell and Gene Therapy Market: Exponential Growth Forecast, Key Players and Emerging Trends

The booming cell and gene therapy market, driven by advances in cancer drug discovery and increased healthcare expenditure, is projected to witness a rapid growth in the coming years.

What Is The Projected Market Size Of The Global Cell and Gene Therapy Market And Its Growth Rate?

• The global market for cell and gene therapy was valued at $12.01 billion in 2024 and is projected to reach $15.48 billion in 2025, growing at a compound annual growth rate (CAGR) of 28.9%.
• The projected growth is attributed to increased investment in these therapies, extensive research and development, favorable economic growth in emerging markets, as well as increasing healthcare expenditure.
• The market value is expected to reach $29.15 billion by 2029, growing at a CAGR of 17.1%, backed by an increasing prevalence of cancer and chronic diseases, a rise in the geriatric population and a focus on cell and gene therapy.

What Is Driving The Growth In The Cell and Gene Therapy Market?

The cell and gene therapy market witnessed steady growth due to regular investments and consolidation. Realizing the potential of the cell and gene therapy market, 16 out of the top 20 largest biopharmaceutical companies have integrated these therapies into their portfolios. According to the BioIndustry Association, cell and gene therapy companies in the UK acquired over 55% of the venture capital funding received by European firms in 2023. The ongoing investment and consolidation in cell and gene therapy led to a rise in production capacity, contributing to the growth of the market. Companies like Purespring Therapeutics, for example, secured a funding of $105 million in October 2024, to support the development of gene therapies for kidney diseases.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

Who Are the Key Players Driving Cell and Gene Therapy Market Growth?

• Biogen Inc.
• Novartis AG
• Gilead Sciences
• Ionis Pharmaceuticals Inc.
• Alnylam Pharmaceuticals Inc.
• ArrowHead Pharmaceuticals Inc.
• Spark Therapeutics
• Bluebird Bio Inc.
• RegenexBio
• Mesoblast Limited
• Biocon
• Cipla
• Stempeutics Research Pvt. Ltd.
• EdiGene Inc.
• Immunochina
• Takara Bio
• Daiichi Sankyo Company,
• Ultragenyx Pharmaceutical Inc,
• Mitsubishi Tanabe Pharma
• Oxford Biomedica plc
• Santen Pharmaceutical Co.

What Are The Key Trends In The Cell and Gene Therapy Market?

• Focusing on advanced therapies such as chimeric antigen receptor (CAR) T-cell therapy
• Undertaking various research initiatives and attaining funding
• Strategic collaborations to integrate advanced technologies
• Developing gene or genome editing tools, notably CRISPR
• Partnering or acquiring competitor companies
• Increasing the number of pipeline studies to develop cell and gene therapies
• Investing in manufacturing facilities expansion

What Are The Segments Of The Global Cell and Gene Therapy Market?

• By Product: Cell Therapy, Gene Therapy
• By Application: Oncology, Neurological Disorders, Other Applications
• By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Which Region Leads The Cell and Gene Therapy Market?

North America was the largest region in the cell and gene therapy market in 2024. The other regions covered in the cell and gene therapy market report include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

What Is Covered In The Cell and Gene Therapy Market Global Market Report?

• Market Size Analysis: Analyze the Cell and Gene Therapy Market size by key regions, countries, product types, and applications.
• Market Segmentation Analysis: Identify various subsegments within the Cell and Gene Therapy Market for effective categorization.
• Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
• Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
• Market Contribution: Evaluate contributions of different segments to the overall Cell and Gene Therapy Market growth.
• Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
• Industry Challenges: Analyze challenges and risks affecting the Cell and Gene Therapy Market.
• Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=3472&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.